Avibactam Sodium; Ceftazidime is Used for treating hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, complicated intra-abdominal infections, and complicated urinary tract infections in both adult and pediatric patients. It was first introduced by Allergan Sales Llc in its drug Avycaz on Feb 25, 2015.

Avibactam Sodium; Ceftazidime Patents

Given below is the list of patents protecting Avibactam Sodium; Ceftazidime, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Avycaz	US7112592	Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents	Jan 07, 2026	Allergan
Avycaz	US7612087	Heterocyclic compounds as inhibitors of beta-lactamases	Nov 12, 2026	Allergan
Avycaz	US8178554	Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents	Jul 24, 2021 (Expired)	Allergan
Avycaz	US8471025	Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt	Aug 12, 2031	Allergan
Avycaz	US8835455	Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt	Oct 08, 2030	Allergan
Avycaz	US8969566	Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof	Jun 15, 2032	Allergan
Avycaz	US9284314	Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof	Jun 15, 2032	Allergan
Avycaz	US9695122	Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof	Jun 15, 2032	Allergan

Add above patents to watchlist

Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳